Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy

Autologous stem cells that have been genetically modified to express dystrophin are a possible means of treating Duchenne Muscular Dystrophy (DMD). To maximize the therapeutic effect, dystrophin construct needs to contain as many functional motifs as possible, within the packaging capacity of the vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Jinhong, Counsell, John R., Reza, Mojgan, Laval, Steven H., Danos, Olivier, Thrasher, Adrian, Lochmüller, Hanns, Muntoni, Francesco, Morgan, Jennifer E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728433/
https://www.ncbi.nlm.nih.gov/pubmed/26813695
http://dx.doi.org/10.1038/srep19750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728433/
https://www.ncbi.nlm.nih.gov/pubmed/26813695
http://dx.doi.org/10.1038/srep19750

Ejemplares similares